Status:
COMPLETED
Obestatin Change in Distal Gastrectomy
Lead Sponsor:
Samsung Medical Center
Conditions:
Gastric Cancer Patients Treated by Subtotal Gastrectomy
Eligibility:
All Genders
18+ years
Brief Summary
According to Seoul cancer registry data (2000), cancer became the leading cause of death in Korea, accounting for 23.9% of all deaths and gastric cancer is the most prevalent malignant neoplasm, compr...
Detailed Description
The below is the items to be included in the study. * diet evaluation: standard three-day diet evaluation table (Dept. of Nutrition) * body weight and height: BMI . * ELISA for plasma ghrelin, leptin...
Eligibility Criteria
Inclusion
- patients with informed consent
- gastric cancer patients treated by subtotal gastrectomy (without chemotherapy or radiation therapy) : Actually the differentiation of EGC or AGC depend on the depth of invasion. Therefore if the patients are not cachetic because of metastasis or tumor burden, there is no need toe exclude the AGC patients from the study.
Exclusion
- patients with chemotherapy or radiation therapy diabetes mellitus: It has been reported that plasma ghrelin is influenced by the insulin. Thus a history of diabetes exclude the enrollment of the protocol.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00822718
Start Date
January 1 2005
End Date
July 1 2007
Last Update
January 14 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.